Document Detail

Salt wasting disorder in the newborn.
MedLine Citation:
PMID:  16444070     Owner:  NLM     Status:  MEDLINE    
The clinical presentation of pseudohypoaldosteronism (PHA) mimics congenital adrenal hyperplasia (CAH). Poor response of the dehydration and electrolyte abnormalities to steroid therapy should make one suspect PHA. The treatment is supportive in the form of salt replacement and sodium resonium. We report a case of PHA that presented as salt wasting on the second day of life, initially appearing like CAH. The baby responded well to sodium resonium and salt replacement.
G Ranjith; Susan Uthup; B Satish; Naveen Jain
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Indian journal of pediatrics     Volume:  73     ISSN:  0973-7693     ISO Abbreviation:  Indian J Pediatr     Publication Date:  2006 Jan 
Date Detail:
Created Date:  2006-01-30     Completed Date:  2006-07-18     Revised Date:  2009-07-15    
Medline Journal Info:
Nlm Unique ID:  0417442     Medline TA:  Indian J Pediatr     Country:  India    
Other Details:
Languages:  eng     Pagination:  95-6     Citation Subset:  IM    
Kerala Institute of Medical Sciences,Trivandrum, Kerala, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenal Hyperplasia, Congenital
Cation Exchange Resins / therapeutic use
Cyclooxygenase Inhibitors / therapeutic use
Diagnosis, Differential
Indomethacin / therapeutic use
Infant, Newborn
Polystyrenes / therapeutic use
Pseudohypoaldosteronism / diagnosis*,  drug therapy,  physiopathology
Saline Solution, Hypertonic / therapeutic use
Reg. No./Substance:
0/Cation Exchange Resins; 0/Cyclooxygenase Inhibitors; 0/Polystyrenes; 0/Saline Solution, Hypertonic; 28210-41-5/polystyrene sulfonic acid; 53-86-1/Indomethacin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Growth in congenital adrenal hyperplasia.
Next Document:  Neonatal pseudohypoparathyroidism.